View Cart  

Par Pharmaceutical Receives Final Approval to Market Tretinoin Capsules

A A
Par Pharmaceutical announced that its operating subsidiary, Anchen Pharmaceuticals, has received final approval from the FDA for its ANDA for tretinoin capsules, 10 mg. 
The Sacramento Bee